Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.210
+0.010 (0.31%)
Jan 21, 2025, 4:00 PM EST - Market closed
Arbutus Biopharma Employees
Arbutus Biopharma had 73 employees as of December 31, 2023. The number of employees decreased by 25 or -25.51% compared to the previous year.
Employees
73
Change (1Y)
-25
Growth (1Y)
-25.51%
Revenue / Employee
$92,356
Profits / Employee
-$1,050,685
Market Cap
608.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ABUS News
- 8 days ago - Arbutus Provides 2025 Corporate and Financial Update - GlobeNewsWire
- 14 days ago - Arbutus: Positive Imdusiran Data Leads To Phase 2B Development - Seeking Alpha
- 7 weeks ago - Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors - Business Wire
- 2 months ago - Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat - GlobeNewsWire
- 2 months ago - Arbutus' Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon - GlobeNewsWire
- 2 months ago - Arbutus to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 2 months ago - Arbutus Biopharma Corporation (ABUS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire